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Jianhong Xu1†, Yueying Zheng1†, Liqing Wang1, Qiang Feng2, Ceyan Yu2 and Shengmei Zhu1*Abstract
A 60 years old chinese male scheduled for a removal of an intracardiac mass occupying majority of right ventricular
space, right ventricular outflow tract and pulmonary artery. The giant cardiac mass was later diagnosed
pathologically as metastatic liposarcoma. The patient had a history of surgical removal of myxoid liposarcoma from
his left thigh many years ago. It is extremely rare for liposarcoma to metastatize to right ventricle and pulmonary
artery. The anesthetic management of the surgical procedure to remove this kind of intracardiac mass poses
significant challenges to anesthesia providers. Our patient developed refractory hypotension after induction of
general anesthesia which necessitated urgent cardiopulmonary bypass. The surgical procedure was successful and
the patient recovered from the surgery and was discharged home without significant complication. Accurate
preoperative diagnosis and assessment of patient’s functional status, appropriate preoperative volume status,
emergency cardiopulmonary bypass readiness, smooth and gentle induction of general anesthesia with less
myocardial depressing agent, and closely monitoring patient’s vitals and hemodynamic parameters are imperative
in managing this kind of patients.
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Metastatic tumors to cardiac chamber(s) are uncommon.
If it occurs, mostly it is due to renal cancer and metasta-
sized to right atrium. Liposarcoma from lower extremity
metastasized into right ventricle (RV) and protruded into
pulmonary artery (PA) is extremely rare [1-4]. We report
this case with the metastatic neoplasm occupying most RV
chamber space and protruding into pulmonary artery.
When we induced general anesthesia, the patient collapsed
hemodynamically. Emergency cardiopulmonary bypass
(CPB) was established. The patient underwent a successful
removal of the metastatic tumor and recovered smoothly
postoperatively. The complete resection of tumor is a rec-
ognized therapy with documented favorable prognosis [5].
The scheduled procedure in this kind of patient poses
unique challenges to the anesthesiologist(s). We will* Correspondence: smzhu20088@163.com
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reproduction in any medium, provided the ordiscuss what we have learned from this case and the poten-
tial challenges anesthesia provider(s) will face.Case presentation
A 60 years old chinese male was admitted to our hospital
with chest tightness, dyspnea, systemic edema, and ab-
dominal distension for more than 1 week. Physical exam-
ination is within normal limits except mild systematic
edema. Electrocardiography (ECG) showed complete right
bundle branch block and RV hypertrophy. The chest X-
ray revealed cardiomegaly (cardiothoracic ratio: 60%). The
transthoracic echocardiography detected a large echogenic
mass (10.4*4.1 cm) which occupied most chamber space
of RV and RV outflow tract (RVOT), was attached to the
RV free wall, and extended into the main pulmonary ar-
tery and its bifurcations. A small pericardial effusion and
left ventricular diastolic dysfunction were also detected.
Computerized tomography (CT) with contrast of the chest
confirmed the presence of the mass, which caused obvious
obstruction of the RVOT (Figure 1). Laboratory results
were unremarkable. The patient had a right bundle branchThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Iodine enhanced computerized tomography of the
patient’s chest. Sagittal view confirmed a large filling defect in the
right ventricle extended into the right pulmonary artery (arrow), rending
almost complete occlusion of the right ventricular outflow tract.
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thigh liposarcoma 20 years ago. With the preoperative
diagnosis of intracardia tumor, the patient was scheduled
for excision of the mass with CPB. On arrival to operating
theatre, O2 (5 L/min) via face mask was administered and
all American Society of Anesthesiologists (ASA) standard
monitors were started. Pulse oxygen saturation (SpO2)
was 98%, and heart rate 100 beats/min. The left radial ar-
terial and large-bore intravenous access was obtained. The
invasive blood pressure was 120/85 mmHg (mean blood
pressure, MBP, 100 mmHg). A double-lumen central ven-
ous catheter (14, 18gauge, 13 cm length from the catheter
tip to the skin; Arrow International, USA) was inserted to
the right internal jugular vein before the induction of
general anesthesia. Then the central venous pressure
(CVP) was measured as 31 mmHg. Lactate Ringer’s so-
lution 1000 ml was administrated, and then the induc-
tion of general anesthesia was performed slowly with
midazolam 2 mg iv, etomidate 8 mg iv, rocuronium 50 mg
iv, sufentanyl 30 μg iv, and scopolamine 0.3 mg iv. During
induction, blood pressure fell about 40 mmHg from base-
line, which responded to phenylephrine (40 μg, iv) and
fluid administration. The results from arterial blood gas
revealed pH 7.30, PaCO2 37, PaO2 89 (FiO2 at 50%). Gen-
eral anesthesia was maintained with propofol (200 mg/h)
and cis-atracurium (10 mg/h), and sufentanyl (iv, intermit-
tently according to hemodynamic changes). Meanwhile,dopamine (3-8 μg/kg/min) was given continuously. MBP
decreased below 60 mmHg after sternal retraction, unre-
sponsive to intravenous fluid and phenylephrine adminis-
tration. Heart rates fluctuated around 90 beats/min. SpO2
maintained at 95-100%. CVP increased to 35 mmHg. The
medication for maintenance of general anesthesia was
turned down temporarily. About 24 minutes after induc-
tion of general anesthesia, urgent CPB was initiated after
intravenous heparine was given. Ulinastatin (30,000 U)
and methylprednisolone (40 mg) were also administrated.
Then the surgery team removed the neoplasm successfully
from the RV, RVOT and pulmonary artery. Total CPB and
aortic cross-clamp times were 90 and 24 minutes, respect-
ively. The patient was weaned from CPB easily with pace-
maker and epinephrine infusion of 6 μg/min. At the
termination of CPB, the pH was 7.30, PaCO2 44 mmHg,
PaO2 276 mmHg with FiO2 80%. After CPB, the patient’s
heart rate was maintained at around 90 beats/min, blood
pressure 90-100/50-60 mmHg, and CVP 9-11 mmHg. The
patient was extubated at postoperative day one in surgical
ICU (intensive care unit) and he was discharged home in a
good condition 11 days postoperatively. The final histo-
pathology report of the tumor mass revealed myxoid lipo-
sarcoma. The post-operative ECG indicated no residual
mass was inside the heart chambers.
Discussion
The occurrence of metastatic liposarcoma to the heart is
rare. Metastatic liposarcoma occurs most likely in the
lungs, liver, lymph node, brain and skeletal system [6].
Only 20 cases of metastatic cardiac liposarcoma were re-
ported in the literature prior to our report [4,7-9]. Diagno-
sis of the isolated heart tumor as being metastatic is
unusual unless the primary site is discovered. Liposarcoma
is one of the most common soft tissue sarcomas, usually
found in the lower extremities. The myxoid of histological
classification accounts about 50% in liopsarcoma sub-
groups, which is characterized by a slow growth and a low
risk for the metastasis. Some authors believe that it may
take 3-25 years to present at a metastatic location [6]. In
our patient, the interval between the appearance of pri-
mary tumor and metastasis was about 20 years.
Clinically, the symptoms of cardiac metastasis are basic-
ally nonspecific. Pericardium is usually involved and peri-
cardial effusion often exists. Heart failure is a common
clinical feature. And cardioembolic stroke, myocardial in-
farction and even death from malignant arrhythmia may
be its serious complications. Generally, cardiac symptoms
appear slowly in onset. Nevertheless, in our case, symp-
toms on admission were 1-week history of clinical symp-
toms related to the right heart failure. Two-dimensional
ECG and CT of the chest are reportedly very accurate in
making the diagnosis and assessing the extent of a cardiac
mass preoperatively, though angiocardiography would
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of patients [10]. The prognosis of the metastatic liposar-
coma is usually poor. Surgery is indicated when complete
resection of tumor is feasible and/or relieving intracardiac
obstruction is necessary [11].
The concerns in anesthetizing these patients with tu-
mors involved in the RV, the RVOT, and even PA include
acute RV failure, hypoxemia, low cardiac output, tampon-
ade, and potential pulmonary emboli. There is no “stand-
ard method” for the anesthetic management of this kind
of surgical procedures. We believe the following strategies
will help manage these patients:
1. Preoperative evaluation: accurate preoperative
diagnosis, assessment of tumor size, location,
involvement of cardiac valves, tumor mobility,
degree of obstruction to blood flow etc and
evaluation of patient’s overall cardiac functional
status and comorbidities;
2. Preoperative volume replacement is very important,
hypovolemia should be avoided;
3. Monitoring: non-thermodilution technique for car-
diac output measurement should be used, because
we cannot insert a pulmonary artery catheter for
these patients. CVP is possible, but the catheter can-
not be too close to superior vena cava-right atrium
junction; Transesophageal ECG will be very helpful
in multiple aspects: confirming diagnosis, assessment
of the mass, evaluation of blood volume status, car-
diac function and comorbidities, monitoring the
evolving process of the surgical procedure. In
addition, it is useful in detecting the tumor fragmen-
tation, dislodgement or embolism [12,13]. Unfortu-
nately we did not use TEE (transesophageal
echocardiography) due to technical difficulties.
4. Emergency CPB readiness: sedating patient for
preoperative invasive line placement, or inducing
general anesthesia can all cause hemodynamic
collapse, so emergency CPB readiness is mandatory.
Surgical sterilizing and draping before the initiation of
induction of anesthesia is also mandatory. In some
report, some authors even suggested to prepare for
femoral-femoral cannulation and bypass [12].
5. Smooth and slow-titration induction of general
anesthesia with less myocardial depressing agent,
and closely monitoring patient’s vitals and
hemodynamic parameters are imperative in man-
aging this kind of patients. Avoidance of sedating
these patients outside of operation room (OR) is also
very important because if patient’s hemodynamic pa-
rameters worsen, emergency CPB is necessary, it is
more favorable if patient is inside the OR.
6. Judicious use of inotropes: inotropes are double-
sides sword for these kinds of patients. When usingappropriately, inotropes can enhance myocardial
contractility and improve hemodynamics. On the
other hand, inotropes can also cause increased con-
tractility which leads to narrower passage for intra-
cardiac blood flow.
We supplemented the patient with 1000 ml of crystal-
loid before the initiation of induction. However, we
were not sure whether the RV preload was full, since
the CVP monitoring might not accuratly reflect the RV
volume status due to the RV mass. Despite of the slow
and careful induction of anesthesia and intravenous
infusion of dopamine for improving RV contractility,
hypotension happened after induction and exacerbated
after sternotomy. This hypotension might be related to
decreased systemic vascular resistance (SVR), which
caused decreased venous return, thus lower cardiac out-
put and hypotension. Another potential mechanism is
the sudden dilatation of RV. Flexman AM et al reported
with TEE monitoring that the distended RV in the con-
dition of acute RV failure forced the interventricular
septum to be shifted the left, which reduced the left
ventricle volume further [12]. In our case, the surgeon
did find the heart congestion during the exploration.
Undoubtedly, TEE measurements would be significantly
useful and helpful for cardiac assessment and monitor-
ing. In addition, delicate performance during surgery is
also crucial for the patient. The surgery team adopted a
special technique of suctioning tumor instead of excision
avoid tumor fragmentation, thus reducing the chance of re-
sidual tumor or tumor migration to other tissue or organs.
Post-operative ECG assesses the completeness of surgical
removal and may reveal some unexpected findings.Conclusions
Giant metastatic cardiac liposarcoma occupying right
ventricle and pulmonary artery is extremely rare. The
anesthetic management of the surgical procedure to re-
move this kind of tumor poses significant challenges to
anesthesia providers. Accurate preoperative diagnosis
and assessment of patient’s functional status, appropri-
ate preoperative volume status, emergency CPB readi-
ness, smooth and gentle induction of general anesthesia
with less myocardial depressing agent, and closely mon-
itoring patient’s vitals and hemodynamic parameters are
imperative in managing this kind of patients.Consent statement
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